Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis

Mult Scler. 2021 Jul;27(8):1311-1312. doi: 10.1177/1352458520969941. Epub 2020 Dec 8.

Authors

Benjamin M Jacobs^{1

2}, Ide Smets³, Gavin Giovannoni^{1

2

3}, Alastair Noyce^{1

2}, Vilija Jokubaitis⁴, Ruth Dobson^{1

2}

Affiliations

¹ Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
² Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK.
³ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
⁴ Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.

PMID: 33289622
DOI: 10.1177/1352458520969941

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Multiple Sclerosis*
Nicotiana
Receptors, Nicotinic*
Tobacco Smoke Pollution*
alpha7 Nicotinic Acetylcholine Receptor

Substances

Receptors, Nicotinic
Tobacco Smoke Pollution
alpha7 Nicotinic Acetylcholine Receptor

Grants and funding

DH_/Department of Health/United Kingdom